Ferroptosis in hepatocellular carcinoma promotes tumor growth and metastasis through a macrophage/IL1β/neutrophil axis, which can induce sorafenib resistance, with targeting this inflammatory pathway enhancing sorafenib efficacy. Here, IL1B is linked to hepatocellular carcinoma.